A Study to Evaluate Safety and PK of Multiple Doses of LT3001 Drug Product and Drug-drug Interaction in Healthy Subjects
Clinical trial NCT04809818 · COMPLETED
Trial details
- NCT number
- NCT04809818
- Sponsor
- Lumosa Therapeutics Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-21
- Primary completion
- 2021-08-05
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.